181 related articles for article (PubMed ID: 33102965)
1. Calcification Biomarkers, Subclinical Vascular Disease, and Mortality Among Multiethnic Dialysis Patients.
Fitzpatrick J; Kim ED; Sozio SM; Jaar BG; Estrella MM; Monroy-Trujillo JM; Parekh RS
Kidney Int Rep; 2020 Oct; 5(10):1729-1737. PubMed ID: 33102965
[TBL] [Abstract][Full Text] [Related]
2. Associations of Serum Calciprotein Particle Size and Transformation Time With Arterial Calcification, Arterial Stiffness, and Mortality in Incident Hemodialysis Patients.
Chen W; Fitzpatrick J; Monroy-Trujillo JM; Sozio SM; Jaar BG; Estrella MM; Serrano J; Anokhina V; Miller BL; Melamed ML; Bushinsky DA; Parekh RS
Am J Kidney Dis; 2021 Mar; 77(3):346-354. PubMed ID: 32800846
[TBL] [Abstract][Full Text] [Related]
3. Coronary Artery Calcification in Hemodialysis and Peritoneal Dialysis.
Jansz TT; van Reekum FE; Özyilmaz A; de Jong PA; Boereboom FTJ; Hoekstra T; Verhaar MC; van Jaarsveld BC
Am J Nephrol; 2018; 48(5):369-377. PubMed ID: 30423550
[TBL] [Abstract][Full Text] [Related]
4. Association of Vitamin K Status with Arterial Calcification and Stiffness in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort.
Shea MK; Wang J; Barger K; Weiner DE; Townsend RR; Feldman HI; Rosas SE; Chen J; He J; Flack J; Jaar BG; Kansal M; Booth SL;
Curr Dev Nutr; 2023 Jan; 7(1):100008. PubMed ID: 37181121
[TBL] [Abstract][Full Text] [Related]
5. Inactive Matrix Gla Protein, Arterial Stiffness, and Endothelial Function in African American Hemodialysis Patients.
Fain ME; Kapuku GK; Paulson WD; Williams CF; Raed A; Dong Y; Knapen MHJ; Vermeer C; Pollock NK
Am J Hypertens; 2018 May; 31(6):735-741. PubMed ID: 29635270
[TBL] [Abstract][Full Text] [Related]
6. Plasma osteoprotegerin, arterial stiffness, and mortality in normoalbuminemic Japanese hemodialysis patients.
Nakashima A; Carrero JJ; Qureshi AR; Hirai T; Takasugi N; Ueno T; Taniguchi Y; Lindholm B; Yorioka N
Osteoporos Int; 2011 Jun; 22(6):1695-701. PubMed ID: 20812007
[TBL] [Abstract][Full Text] [Related]
7. The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis.
Shroff RC; Shah V; Hiorns MP; Schoppet M; Hofbauer LC; Hawa G; Schurgers LJ; Singhal A; Merryweather I; Brogan P; Shanahan C; Deanfield J; Rees L
Nephrol Dial Transplant; 2008 Oct; 23(10):3263-71. PubMed ID: 18463323
[TBL] [Abstract][Full Text] [Related]
8. Inactive Matrix Gla-Protein and Arterial Stiffness in Type 2 Diabetes Mellitus.
Sardana M; Vasim I; Varakantam S; Kewan U; Tariq A; Koppula MR; Syed AA; Beraun M; Drummen NE; Vermeer C; Akers SR; Chirinos JA
Am J Hypertens; 2017 Feb; 30(2):196-201. PubMed ID: 27927630
[TBL] [Abstract][Full Text] [Related]
9. Inactive Matrix Gla-Protein Is Associated With Arterial Stiffness in an Adult Population-Based Study.
Pivin E; Ponte B; Pruijm M; Ackermann D; Guessous I; Ehret G; Liu YP; Drummen NE; Knapen MH; Pechere-Bertschi A; Paccaud F; Mohaupt M; Vermeer C; Staessen JA; Vogt B; Martin PY; Burnier M; Bochud M
Hypertension; 2015 Jul; 66(1):85-92. PubMed ID: 25987667
[TBL] [Abstract][Full Text] [Related]
10. Serum osteoprotegerin is associated with vascular stiffness and the onset of new cardiovascular events in hemodialysis patients.
Lee JE; Kim HJ; Moon SJ; Nam JS; Kim JK; Kim SK; Yun GY; Ha SK; Park HC
Korean J Intern Med; 2013 Nov; 28(6):668-77. PubMed ID: 24307842
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers of vascular calcification and mortality in patients with ESRD.
Scialla JJ; Kao WH; Crainiceanu C; Sozio SM; Oberai PC; Shafi T; Coresh J; Powe NR; Plantinga LC; Jaar BG; Parekh RS
Clin J Am Soc Nephrol; 2014 Apr; 9(4):745-55. PubMed ID: 24458076
[TBL] [Abstract][Full Text] [Related]
12. The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study.
Parker BD; Schurgers LJ; Brandenburg VM; Christenson RH; Vermeer C; Ketteler M; Shlipak MG; Whooley MA; Ix JH
Ann Intern Med; 2010 May; 152(10):640-8. PubMed ID: 20479029
[TBL] [Abstract][Full Text] [Related]
13. Desphospho-uncarboxylated matrix Gla protein is associated with increased aortic stiffness in a general population.
Mayer O; Seidlerová J; Wohlfahrt P; Filipovský J; Vaněk J; Cífková R; Windrichová J; Topolčan O; Knapen MH; Drummen NE; Vermeer C
J Hum Hypertens; 2016 Jul; 30(7):418-23. PubMed ID: 26016598
[TBL] [Abstract][Full Text] [Related]
14. Diabetes Mellitus Modifies the Associations of Serum Magnesium Concentration With Arterial Calcification and Stiffness in Incident Hemodialysis Patients.
Chen W; Fitzpatrick J; Monroy-Trujillo JM; Sozio SM; Jaar BG; Estrella MM; Wu TT; Melamed ML; Parekh RS; Bushinsky DA
Kidney Int Rep; 2019 Jun; 4(6):806-813. PubMed ID: 31194171
[TBL] [Abstract][Full Text] [Related]
15. Correlations of Plasma Desphosphorylated Uncarboxylated Matrix Gla Protein with Vascular Calcification and Vascular Stiffness in Chronic Kidney Disease.
Thamratnopkoon S; Susantitaphong P; Tumkosit M; Katavetin P; Tiranathanagul K; Praditpornsilpa K; Eiam-Ong S
Nephron; 2017; 135(3):167-172. PubMed ID: 27951533
[TBL] [Abstract][Full Text] [Related]
16. Higher levels of circulating desphospho-uncarboxylated matrix Gla protein over time are associated with worse survival: the prospective Maastricht Intensive Care COVID cohort.
Mulder MMG; Schellens J; Sels JEM; van Rosmalen F; Hulshof AM; de Vries F; Segers R; Mihl C; van Mook WNKA; Bast A; Spronk HMH; Henskens YMC; van der Horst ICC; Cate HT; Schurgers LJ; Drent M; van Bussel BCT
J Intensive Care; 2023 Dec; 11(1):63. PubMed ID: 38111069
[TBL] [Abstract][Full Text] [Related]
17. Progression of arterial stiffness is associated with changes in bone mineral markers in advanced CKD.
Krishnasamy R; Tan SJ; Hawley CM; Johnson DW; Stanton T; Lee K; Mudge DW; Campbell S; Elder GJ; Toussaint ND; Isbel NM
BMC Nephrol; 2017 Sep; 18(1):281. PubMed ID: 28870151
[TBL] [Abstract][Full Text] [Related]
18. Association of desphospho-uncarboxylated matrix gla protein with incident cardiovascular disease and all-cause mortality: Results from the prospective Bruneck Study.
Willeit K; Santer P; Tschiderer L; Pechlaner R; Vermeer C; Willeit J; Kiechl S
Atherosclerosis; 2022 Jul; 353():20-27. PubMed ID: 35764030
[TBL] [Abstract][Full Text] [Related]
19. Associations of fetuin-A and osteoprotegerin with arterial stiffness and early atherosclerosis in chronic hemodialysis patients.
Pateinakis P; Papagianni A; Douma S; Efstratiadis G; Memmos D
BMC Nephrol; 2013 Jun; 14():122. PubMed ID: 23758931
[TBL] [Abstract][Full Text] [Related]
20. Serum osteoprotegerin is an independent marker of central arterial stiffness as assessed using carotid-femoral pulse wave velocity in hemodialysis patients: a cross sectional study.
Hou JS; Lin YL; Wang CH; Lai YH; Kuo CH; Subeq YM; Hsu BG
BMC Nephrol; 2019 May; 20(1):184. PubMed ID: 31122190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
